Under the Medicare National Coverage Determination, if FDA grants traditional approval to other drugs in this class, Medicare will cover them using this same coverage framework, CMS said. In June, CMS released details about how people can get drugs that may slow the progression of Alzheimer's disease covered by Medicare.

Early access to new cancer drugs, granted accelerated approval by the U.S. Food and Drug Administration (FDA), has provided mixed benefits for patients while costing Medicare billions of dollars, reveals research published in the journal BMJ Medicine.

The Centers for Medicare & Medicaid Services said Thursday that it will pay for new Alzheimer’s drugs that are granted full approval from the Food and Drug Administration, although it will require physicians to collect data about how well the drugs ...

Alzheimer's disease drug Leqembi recently secured full approval from the Food and Drug Administration (FDA), and more expansive coverage from Medicare followed. But experts warn this could have long-term ramifications on the program's financial health.

The latest data showcases sustained support for some form of publicly funded health care, as the ACA has maintained an approval rating at or above 50 percent for the past six years, and has had plurality support from voters for the past eight years.

FILE - This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. On Thursday, July 6, 2023, U.S. officials granted full approval to the closely watched Alzheimer’s drug, clearing the way for Medicare and other ...

Some Medicare recipients are set to experience a new “prior authorization” measure as the Centers for Medicare & Medicaid Services (CMS) trials its much-discussed “Wasteful and Inappropriate Service Reduction (WISeR)” model. The initiative ...

Artificial intelligence will soon be used for prior authorization for certain Medicare services in Texas and five other states.

Who among us is looking forward to getting older in 2024? Not senators (most of whom are 65 and older), the two leading presidential candidates (100% of whom are over 75), or the eight Cabinet members who are already more than 65 (growing to 10 in February).

The Centers for Medicare & Medicaid Services (CMS) has withdrawn its approval of the Board of Certification/Accreditation (BOC) as an accreditation organization for suppliers of durable medical equipm

Medicare covers various durable medical equipment (DME) if a healthcare professional prescribes them. People should ensure that the DME supplier participates with Medicare. Covered DME ranges from large items, such as hospital beds for home use, to small ...